Use of retrospective continuous glucose monitoring for optimizing management of type 2 diabetes in India

Journal of Association of Physicians of India

Volumn 64, Issue APRIL, 2016, Pages 16-21

  Mohan, Viswanathan ^a   Jain, Sunil ^b   Kesavadev, Jothydev ^c   Chawla, Manoj ^d   Mutha, Abhay ^e   Viswanathan, Vijay ^f   Saboo, Banshi ^g   Kovil, Rajiv ^h   Mithal, Ambrish ⁱ   Punatar, Dharmen ^j   Shin, John ^k  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b TOTALL Diabetes Hormone Institute   (India)

^c Jothydev's Diabetes and Research Center   (India)

^d Lina Diabetes Care Centre   (India)

^e Diabetes Care and Research Foundation   (India)

^f MV Hospital for Diabetes   (India)

^g Department of Research   (India)

^h Dr Kovil s Diabetes Care Centre   (India)

ⁱ MEDANTA THE MEDICITY   (India)

^j Diab Care Centre   (India)

^k Clinical Research Biostatistics and Bioinformatics   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

BLOOD; BLOOD GLUCOSE MONITORING; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; INSULIN; RETROSPECTIVE STUDIES;

EID: 84962409056     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Anjana RM, Pradeepa R, Deepa M, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR INDIAB) study. Diabetologia 2011; 54:3022-7.
2. Unnikrishnan R, Anjana RM, Deepa M, et al. Glycemic control among individuals with self-reported diabetes in India-the ICMRINDIAB Study. Diabetes Technol Ther 2014; 16:596-603.
3. Strain WD, Cos X, Hirst M, et al. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract 2014; 105:302-12.
4. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19:644-55.
5. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005; 7:253-63.
6. Kannampilly J, Paleri A, Valsan A. The benefit of continuous glucose monitoring system(CGMS-IPR02) in reducing A1C in suboptimally controlled type 2 diabetes. Diabetes Technol Ther 2014; 16:A71.
7. Kim SK, Kim HJ, Kim T, et al. Effectiveness of 3-day continuous glucose monitoring for improving glucose control in type 2 diabetic patients in clinical practice. Diabetes Metabolism J 2014; 38:449-55.
8. Cokolic M, Krajnc M, Sternad S, Rakusa M. The use of continuous glucose monitoring devi ce: i Pro2 i mproves l ong-term management of diabetes mellitus. Diabetes Technol Ther 2013; 15:A57-A8.
9. Blackberry ID, Furler JS, Ginnivan LE, et al. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study. Diabetes Res Clin Pract 2014; 106:247-55.
10. Paramasivam SS, Tan ATB, Chan SP, et al. The effect of professional continuous glucose monitoring on glycaemic control and hypoglycaemia in insulin-requiring gestational diabetes mellitus. Diabetologia 2014; 57:S449.
11. Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. Clinical utility of CGM in pre-diabetes and its impact on modifying lifestyles. Diabetes Technol Ther 2014; 16:A41.
12. Zucchini S, Scipione M, Predieri B, et al. Usefulness of CGM with iPro2 in children with T1DM and correlations between Glucose Variability and metabolic control. Pediatr Diabetes 2012; 3:118.